[
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE) Finalizes Global Licensing Agreement with 3sbio, Inc.",
    "summary": "Pfizer Inc. (NYSE:PFE) is among the 12 Best Ethical Companies to Invest in 2025. On July 24, 2025, Pfizer Inc. (NYSE:PFE) finalized the global licensing agreement with 3SBio, Inc. With this agreement, PFE acquired the exclusive rights to develop, manufacture, and commercialize 3SBio’s SSGJ-707, a bispecific antibody for PD-1 and VEGF. Leveraging 3SBio’s proprietary CLF2 […]",
    "url": "https://finnhub.io/api/news?id=2008103676f2fa6a7e7245e8b5fe2f2217cecfcba4ea6a0560db3372f99bbecc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753625792,
      "headline": "Pfizer Inc. (PFE) Finalizes Global Licensing Agreement with 3sbio, Inc.",
      "id": 136101892,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer Inc. (NYSE:PFE) is among the 12 Best Ethical Companies to Invest in 2025. On July 24, 2025, Pfizer Inc. (NYSE:PFE) finalized the global licensing agreement with 3SBio, Inc. With this agreement, PFE acquired the exclusive rights to develop, manufacture, and commercialize 3SBio’s SSGJ-707, a bispecific antibody for PD-1 and VEGF. Leveraging 3SBio’s proprietary CLF2 […]",
      "url": "https://finnhub.io/api/news?id=2008103676f2fa6a7e7245e8b5fe2f2217cecfcba4ea6a0560db3372f99bbecc"
    }
  }
]